Skip to content
thestock.space

As of 6 Nov 2026, Global Health trades at 60.4× trailing earnings, above the industry P/E of 47.7×, and the shares are 10% below their 52-week high. Its ROCE of 15% is the second-highest among the 7 largest Medical Care Facilities peers, and sales and net profit grew 17% and 19% a year over 3 years. Debt is 0.31× equity. It is a mid-cap company with a market cap of ₹37,264 Cr, ranked 7th of 40 Medical Care Facilities companies by market cap; the shares rose 11% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹1,390.00
Day high
₹1,421.00
Day low
₹1,382.80
Prev. close
₹1,389.70
Volume
1 L

Health check

3 good · 2 fair · 1 to check
  • ReturnsAhead

    +11.2% over a year, better than 7 of 7 peers.

  • Price tagPricier

    P/E 60.4 vs industry 47.7.

  • GrowthSteady

    Sales +17.2%, profit +19.5% a year over 3 years.

  • ProfitabilityAverage

    ROCE 15.0% vs peer median 11.4%.

  • Balance sheetSolid

    Debt 0.31× equity, interest covered 10.2×, Piotroski 6 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Mid cap

₹37,264 Cr, #7 of 40 in its industry by size.

Defensive

Beta 0.23 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹5,053 Cr · profit ₹618 Cr
Market cap
₹37,264 Cr
Mid cap
P/E
60.4
Industry 47.7
Price to book
8.63
Peers 8.06
Dividend yield
0.04%
ROE
15.2%
Peers 11.0%
ROCE
15.0%
Peers 11.4%
Debt to equity
0.31
Debt ₹1,353 Cr
EPS (TTM)
₹22.98
Face value ₹2
OPM (TTM)
22.1%
Net margin 12.2%
Sales growth
+33.6%
Latest quarter vs a year ago
Profit growth
+39.3%
Latest quarter vs a year ago
Price to sales
7.37
EV/EBITDA 34.1

Strengths and risks

Strengths

  • Quarterly profit up 39.3% on a year ago.
  • Quarterly sales up 33.6% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Global Health

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine,…

Headquarters
Gurugram
Employees
12,600
Sector
Healthcare
ISIN
INE474Q01031
Website
medanta.org

Price range

52 weeks

₹956.00₹1,544.00

Today

₹1,382.80₹1,421.00
Avg volume (3M)
2.8 L
1-year return
plus 11.2%
From 52-week high
minus 10.1%

Analyst consensus

19 analysts
Strong buyMean target ₹1,611.68 plus 16.1%

Target range, with today’s price

Low ₹1,390.00High ₹1,799.00

Today’s price ₹1,387.60 is below the lowest analyst target.

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
KIMSKrishna Institute of Medical Sciences723.00minus 1.10%30,366138.512.878.1%11.0%19.8%21.3%−10.5%0.00%plus 2.0%
Median of 7 peers–−0.89%62,09266.18.0611.4%11.0%18.5%18.1%9.6%0.21%2.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
1,0991,1211,1591,3041,469
8689049151,0171,099
231217244287370
21.0%19.4%21.0%22.0%25.2%
19.721.836.722.223.6
17.121.526.726.728.1
49.761.266.56970.8
16−36.6–––
200120187213295
20.7%20.7%24.4%26.3%25.7%
15895144159221
5.893.545.355.908.20

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+17.2%
Profit CAGR 3Y
+19.5%
EPS CAGR 3Y
+18.0%
ROE
15.2%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
2,6833,2413,6374,318
–+20.8%+12.2%+18.7%
2,0342,4102,7063,369
649831931949
24.2%25.6%25.6%22.0%
3660.785.983.8
77.572.56478
150173194223
−8.3−19.3−111−17.5
449627647715
27.4%23.8%25.6%22.5%
326478481556
–+46.6%+0.7%+15.6%
12.5717.8017.9220.66

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
53.653.753.753.7
2,3752,8523,3333,908
1,1228027181,190
566597662753
4,1164,3044,7665,905
2,3722,6183,0363,911
327386529132
33.310.418.288.6
1,2601,1561,0511,106
123133133667
4,1164,3044,7665,905

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
645612624714
−342−441−721−1,089
346−514−97.2272
648−343−194−103
−236−279−648−979
409333−24.2−264
–––−13.4

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 23.5% (Yahoo estimate).

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you